4th European Clinical Trials Inspection Readiness
May 21 - 22, 2018 - Radisson Blu Portman Hotel, 22 Portman Square, London UKExL Events
cventurina@exlevents.com
Phone:9172585158
During clinical trials, inspections provide a framework to ensure quality and integrity of care, data and drug performance. As sponsors of clinical trials, it is important for pharmaceutical companies to ensure GCP guidelines are upheld by implementing inspection readiness. These inspections, often conducted by the FDA, EMA, MHRA and other regulatory authorities, all have unique regulations and caveats. These nuances mean that becoming - and remaining - inspection-ready can be a difficult, time-consuming battle. Because inspections can occur without notice, sites must be prepared for visits from many different stakeholders over the course of a clinical trial. Join the 4th European Clinical Trials Inspection Readiness Summit and inspire an organisational culture that prioritises inspection readiness as integral to the success of your organisation. Unfavourable inspection findings can delay trials, result in costly corrective measures and shut down drug development. Concentrating on more areas of inspection readiness - such as metrics, data integrity and technology - can guarantee findings are never a surprise. Organisational culture is often thought to be an unchangeable and steadfast belief system, but is more accurately represented as a state that must evolve to stay relevant. At the 4th European Clinical Trials Inspection Readiness Summit, our esteemed faculty will address the importance of fostering a culture of inspection readiness within your organisation, as well as ways to do so. With interactive sessions, case studies and panel discussions about effective communication pathways, integrated technology application and standardised operating procedures, you will return to work prepared to change your organisation to embrace a culture that continually places quality first.